Cerba Lancet Africa
Cerba Lancet Africa is a South Africa-headquartered, privately held clinical pathology network operating 160 ISO 15189-accredited laboratories across 14 African countries, serving approximately 124,900 patients and 407,000 tests per month from a 4,000+ test catalogue for patients, healthcare providers, corporate clients, and clinical-trial sponsors.
- Company typePrivate
- Founded2018
- HeadquartersJohannesburg, South Africa
- Headcount501–1,000
- GTM typeB2B and B2C
- OfferingServices
What Cerba Lancet Africa does
Cerba Lancet Africa is a pan-African operator of clinical pathology and medical diagnostic laboratories, registered in South Africa as Cerba Lancet RSA (PTY) LTD and headquartered in Johannesburg. It runs 160 laboratory and collection sites across 14 African countries — Botswana, Eswatini, Ethiopia, Gabon, Ghana, Ivory Coast, Kenya, Mozambique, Nigeria, Rwanda, Tanzania, Uganda, Zambia, and Zimbabwe — through wholly-owned country subsidiaries carrying the Lancet and Cerba Path brands. The company positions itself as the leading clinical pathology network on the continent, processing an average of 407,000 tests and serving 124,900 patients per month from a catalogue of more than 4,000 tests, with ISO 15189 accreditation across the network.
The core business is routine and specialized pathology testing delivered to patients via walk-in laboratory visits and to healthcare providers via referral channels. Around this core, the company operates four service lines: Pathology Services (the diagnostic testing offering), Customer Services (patient-facing sample collection, result delivery, and support, with country-specific variations), Corporate Services (occupational health, workplace wellness, and employee assessments), and Clinical Research & Clinical Trial services (laboratory support for pharmaceutical sponsors and research institutions). Two branded preventive-medicine assets — a Wellness Center in Nigeria and a Medical Centre in Kenya — extend the offering into consumer screening. Distribution is overwhelmingly physical: a direct lab network, healthcare-provider referrals, and corporate wellness contracts, supplemented by a website with lab-locator and test-catalogue functionality. Pricing is not publicly disclosed and operates on a pay-as-you-go, quote-based model varying by country, test type, and insurance status.
The revenue model combines recurring test volume (high-volume, low-ticket consumer and provider referrals) with project-based professional services revenue from clinical-trial sponsors and corporate wellness clients. The company is privately held with no disclosed external investors, no public listing, and no revenue disclosure; ownership references indicate affiliation with the broader Cerba Group and Lancet South Africa through inter-company data and operational arrangements. No AI/ML capabilities, APIs, or digital product platforms are disclosed.
Cerba Lancet Africa firmographics
Firmographics- Name
- Cerba Lancet Africa
- Legal name
- Cerba Lancet RSA (PTY) LTD
- Website
- https://cerbalancetafrica.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Cerba Lancet Africa is a South Africa-headquartered, privately held clinical pathology network operating 160 ISO 15189-accredited laboratories across 14 African countries, serving approximately 124,900 patients and 407,000 tests per month from a 4,000+ test catalogue for patients, healthcare providers, corporate clients, and clinical-trial sponsors.
- Ownership category
- akta.pro rank
Cerba Lancet Africa industry classification
Industry- Product category
- Clinical Diagnostic Laboratory Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Central Laboratory Services (Core Lab Operations) (HLAGAEAA)
- akta.pro secondary industries
- Clinical Research & Trial Central Laboratories (HLAFAMAL), Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC)
Keywords
Where Cerba Lancet Africa is headquartered
LocationHeadquarters
- HQ city
- Johannesburg
- HQ country
- South Africa
- HQ region
- Africa
Offices15 records
Markets served
Cerba Lancet Africa business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Pathology Services: Clinical pathology and medical diagnostic testing services provided directly to patients and healthcare providers through a network of 160 laboratory sites across Africa
- Clinical Research & Clinical Trials: Clinical research services and clinical trial support provided to pharmaceutical companies and healthcare institutions
- Corporate Services: Workplace health and safety services including occupational health assessments and wellness programs for corporate clients
- Customer Services: Patient-facing laboratory services combining expertise and proximity, with services varying by country
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Medical diagnostic testing services - pricing varies by test type and country |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Cerba Lancet Africa product offering
Product offeringCore offering
Cerba Lancet Africa operates a pan-African network of ISO 15189-accredited clinical pathology and medical diagnostic laboratories. It delivers laboratory testing across a 4,000+ test catalogue through 160 sites in 14 African countries, complemented by corporate wellness/occupational health services, clinical research and clinical trial support, and preventive medicine centers in Nigeria and Kenya.
Product overview
Cerba Lancet Africa operates as a unified network of clinical pathology and medical diagnosis laboratories across Africa. The company offers a comprehensive portfolio of diagnostic services including Pathology Services (the core laboratory testing and analysis offering), Customer Services (patient-facing support and sample management), Corporate Services (occupational health for businesses), and Clinical Research & Clinical Trial services. Additionally, the company provides preventive medicine through dedicated Wellness Centers (Nigeria) and Medical Centres (Kenya). With a catalogue of 4,000 tests, 160 sites, and an average of 407,000 monthly tests across 14 African countries, the company positions itself as the leading medical diagnostic network in Africa.
Differentiator
Problem solved
Functional benefit
Products and services
- Pathology Services Clinical pathology and medical diagnostic services including laboratory testing, sample analysis, and result reporting for patients and healthcare providers across Africa. Core diagnostic offering with access to a 4,000+ test catalogue.
- Customer Services Patient-facing services combining expertise and proximity, including sample collection, result delivery, and customer support, with service mix varying by country.
- Corporate Services Workplace health and occupational health services for businesses, including employee health assessments, occupational health compliance, and workplace wellness programs.
- Clinical Research & Clinical Trial Clinical research services and laboratory support for clinical trials provided to pharmaceutical companies and research institutions, leveraging the accredited lab network and 4,000+ test catalogue.
- Wellness Center (Nigeria) Preventive medicine and wellness services offering health screenings and wellness programs for patients in Nigeria.
- Medical Centre (Kenya) Preventive medicine and medical centre services providing health assessments and wellness programs for patients in Kenya.
Quantifiable outcome
- 407,000 average monthly tests performed across the network
- +2 more outcomes
Companies that use Cerba Lancet Africa
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles4 records
Cerba Lancet Africa technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Cerba Lancet Africa partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered minor.
- Lancet South AfricaminorLancet South Africa is mentioned in the privacy policy as a Cerba Group entity to which personal data may be transferred for certain tool supply purposes. This represents an inter-company data sharing arrangement within the Cerba network.
- Cerba Group EntitiesminorThe privacy policy mentions that Cerba Lancet Africa may transfer personal data to other Cerba Group entities and service providers for website management and tool supply purposes.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Cerba Lancet Africa competitors and assessment
Company assessmentBroad incumbents
- Eurofins Scientific: Global testing and laboratory services group operating clinical diagnostics and life-sciences testing across multiple continents, including emerging markets; competes for clinical trial and reference lab contracts in Africa.
- Sonic Healthcare: Global medical diagnostics company with laboratory networks in Australia, Europe, and the US and a strategic focus on specialty pathology; a comparable scaled operator pursuing cross-border expansion.
- Synlab: Europe-headquartered global medical diagnostics services provider with growing presence in Africa; offers a comparable clinical pathology and reference lab value proposition to large hospital and B2B clients.
Emerging players
- Metropolis Healthcare: India-headquartered diagnostic chain with pan-India presence and selective international expansion in Africa; competes for cross-border reference testing and clinical research volumes in similar emerging markets.
- Dr. Lal PathLabs: Large Indian diagnostic network pursuing international growth through a network of collection centers and reference labs; relevant comparable for patient-volume-driven pathology economics.
Regional players
- National Health Laboratory Service (NHLS): South Africa's public-sector pathology laboratory network serving government hospitals; competes indirectly for talent and reference testing capacity in the same African geographies as Cerba Lancet Africa.
Direct peers
- Lancet Laboratories South Africa: The original South African Lancet network from which Cerba Lancet Africa was formed; operates a comparable clinical pathology and medical diagnostic service across South Africa and is explicitly referenced as a Cerba Group affiliate in the company's privacy policy.
- PathCare: One of South Africa's largest private pathology laboratory networks offering routine and specialized diagnostic testing to clinicians, hospitals, and corporate clients — directly comparable service mix and patient base.
- Ampath (Drs Du Buisson, Kramer, Mokoena & Partners): Major South African private pathology practice and laboratory network providing clinical diagnostics to referring doctors and hospitals, with overlapping test menus and corporate wellness offerings.
Others
- Roche Diagnostics: Global IVD and diagnostics platform supplying instruments, reagents, and increasingly integrated lab services to networks like Cerba Lancet Africa; not a direct competitor but a key supplier and adjacent ecosystem participant shaping competitive dynamics.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Cerba Lancet Africa social profiles
Digital presenceCerba Lancet Africa compliance and trust
Trust signalCompliance1 record
Cerba Lancet Africa financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cerba Lancet Africa leadership team
Management profileNumber of profiles
Cerba Lancet Africa subsidiaries and ownership
Company hierarchySubsidiaries14 records
Cerba Lancet Africa funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cerba Lancet Africa M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cerba Lancet Africa
What does Cerba Lancet Africa do?
Cerba Lancet Africa operates a pan-African network of ISO 15189-accredited clinical pathology and medical diagnostic laboratories. It delivers laboratory testing across a 4,000+ test catalogue through 160 sites in 14 African countries, complemented by corporate wellness/occupational health services, clinical research and clinical trial support, and preventive medicine centers in Nigeria and Kenya.
Is Cerba Lancet Africa a public or private company?
Cerba Lancet Africa is a private company. It is classified as corporate owned and is currently operating.
When was Cerba Lancet Africa founded?
Cerba Lancet Africa was founded in 2018. It employs 501 to 1,000 people.
Where is Cerba Lancet Africa based?
Cerba Lancet Africa is headquartered in Johannesburg, South Africa, in the Africa region.
How does Cerba Lancet Africa make money?
Four revenue lines are on record. Pathology Services are the primary driver. The others are clinical Research & Clinical Trials, corporate Services and customer Services.
Who are Cerba Lancet Africa's main competitors?
Broad incumbents on record are Eurofins Scientific, Sonic Healthcare and Synlab. Emerging players are Metropolis Healthcare and Dr. Lal PathLabs. National Health Laboratory Service (NHLS) is listed as a regional player. Direct peers are Lancet Laboratories South Africa, PathCare and Ampath (Drs Du Buisson, Kramer, Mokoena & Partners). Roche Diagnostics is listed as an others.
Does Cerba Lancet Africa have an API?
No public API is recorded for Cerba Lancet Africa.
What industry is Cerba Lancet Africa in?
Cerba Lancet Africa's product category is Clinical Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAGAEAA, Central Laboratory Services (Core Lab Operations), with a secondary code of HLAFAMAL, Clinical Research & Trial Central Laboratories. Its NAICS code is 621511 and its SIC code is 8071.